Faculty & Staff Details

	Name:	Ameya Shrikant Paranjpe
	Position:	Research Assistant
	Email:	ameya.paranjpe@ttuhsc.edu
	Bio	Ameya Paranjpe completed his Bachelor of Pharmacy degree from the University of Pune, India, in 2007. He continued with his education receiving his Master's of Pharmacy (Pharmaceutics) in 2009 from Bharati Vidyapeeth University in Pune, India. Ameya joined the Department of Biomedical Sciences at TTUHSC as a Ph.D. student with the Graduate Program in Pharmaceutical Sciences in August 2009. At present he is working in Dr. Kalkunte Srivenugopal’s laboratory.

B.Pharm - Pharmaceutical Sciences, University of Pune, India. 2007
M.Pharm - Pharmaceutics, Bharati Vidyapeeth University,Pune, India. 2009

Presentations:

Ameya S. Paranjpe, Mohd. Aslam Yusuf and K. Srivenugopal. Targeting the Redox-Sensing Posttranslational Modifications as a Novel Anticancer Therapeutic Strategy. Research Days, TTUHSC SOP Amarillo. 6/10
Ameya Paranjpe and Kalkunte S. Srivenugopal. "Potent Redox-Based Inhibition of Human MGMT for Improving the Efficacy of Anticancer Alkylating Agents". TTUHSC 2011 Annual Cancer Symposium, Amarillo. 4/11
Ameya Paranjpe and Kalkunte S. Srivenugopal. "Potent Redox-Based Inhibition of Human MGMT for Improving the Efficacy of Anticancer Alkylating Agents". Tenth Annual Research Days, Amarillo. 6/11
Podium Presentation. Ameya Paranjpe and Kalkunte Srivenugopal. “Discovery and Characterization of Nitroaspirin (NCX-4016) as a Mechanism-based, Potent and Clinically Feasible Inhibitor of Human MGMT for Increasing the Efficacy of Anti-cancer Alkylating Agents”. SOP Research Days, 6/12-13/12, Amarillo

Seminars:

"Potent Redox-Based Inhibition of MGMT for Improved Anticancer Strategy" 11/3/10
"Discovery and Characterization of Nitroaspirin (NCX4016) as a Powerful and Clinically Relevant Inhibitor of Human MGMT for Increasing the Efficacy of Alkylating Agents" 11/30/11

Awards/Scholarships:

Memberships: